Novo Nordisk makes the case it’s more than Wegovy in new corporate ad campaign
While social media is abuzz witth Novo Nordisk’s diabetes and obesity medicines Ozempic and Wegovy, it’s probably safe to say far fewer TikTokers and Instagrammers know much about the company behind the drugs.
Novo Nordisk wants to change that with the debut of a first-ever, broad-scale corporate advertising campaign that pulls the curtain back on the company. Initially launched in late April, the US campaign is called “The Greats,” referring to the patients it serves, and it’s now fully rolled out across connected TV, social media, digital and national cinema advertising.
To read Endpoints News become a free subscriber
Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters